Acrospire Investment Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-1,800
Closed -$238K 733
2017
Q2
$238K Buy
1,800
+1,600
+800% +$204K 0.22% 9
2017
Q1
$25K Buy
+200
New +$23.9K 0.02% 1492
2016
Q4
Sell
-715
Closed -$84K 2320
2016
Q3
$84K Buy
715
+100
+16% +$12.1K 0.06% 686
2016
Q2
$75K Sell
615
-300
-33% -$34.1K 0.06% 732
2016
Q1
$99K Buy
+915
New +$94.7K 0.07% 324

Other funds holding JNJ

Acrospire Investment Management's JNJ Position: Q3 2017 in Review

Acrospire Investment Management sold out of Johnson & Johnson (JNJ) in Q3 2017, closing a stake of 1,800 shares — an estimated $238K sold.

Acrospire Investment Management first reported a position in JNJ in Q1 2016 and held it in 5 quarters. The position peaked at $238K in Q2 2017. 2,356 funds tracked by Wall St. Rank hold JNJ as of Q3 2017.

  • Acrospire Investment Management reported no remaining Johnson & Johnson position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 1,800 Johnson & Johnson shares in Q3 2017, an estimated $238K.
  • Acrospire Investment Management first reported a position in Johnson & Johnson in Q1 2016 and held it in 5 quarters.
  • Acrospire Investment Management's Johnson & Johnson position peaked at $238K in Q2 2017.
  • 2,356 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.